SIRS and Sepsis-Induced Neuromuscular Dysfunctions

  • C. F. Bolton
Conference paper


Sepsis [1] has been increasingly associated with a severe systemic response to infection, usually resulting in early death. However, sepsis may be evoked in the absence of infection (e.g. trauma and bums), thus the term “systemic inflammatory response syndrome” or SIRS [2] is now used. Considering the profound changes induced by SIRS, it is not surprising that the nervous system is affected (Fig. 1). The chief manifestations are septic encephalopathy and critical illness polyneuropathy, each occurring in approximately 70% of septic patients [3].


Systemic Inflammatory Response Syndrome Critical Care Unit Neuromuscular Blocking Agent Critical Illness Polyneuropathy Critical Illness Myopathy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Critchley M (ed) (1978) Butterworths Medical Dictionary. 2nd ed. Butterworths, Boston: 1415Google Scholar
  2. 2.
    American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20;6:864–874CrossRefGoogle Scholar
  3. 3.
    Bolton CF (1993) Neuromuscular complications of sepsis. Intens Care Med 19:S58-S63CrossRefGoogle Scholar
  4. 4.
    Bolton CF (1996) Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations. Crit Care Med 24:1408–1416PubMedCrossRefGoogle Scholar
  5. 5.
    Bolton CF (1987) Electrophysiologic studies of critically ill patients. Muscle & Nerve 10: 129–135CrossRefGoogle Scholar
  6. 6.
    Bolton CF (1993) Clinical neurophysiology of the respiratory system. AAEM Minimonograph #40. Muscle & Nerve 16:809–818CrossRefGoogle Scholar
  7. 7.
    Young GB, Bolton CF, Austin TW et al (1990) The encephalopathy associated with septic illness. Clin Invest Med 13:297–304PubMedGoogle Scholar
  8. 8.
    Young GB, Bolton CF, Austin TW et al (1991) The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 9:145–152Google Scholar
  9. 9.
    Zochodne DW, Bolton CF, Wells GA et al (1987) Critical illness polyneuropathy: A complication of sepsis and multiple organ failure. Brain 110:819–842PubMedCrossRefGoogle Scholar
  10. 10.
    Maher J, Rutiedge F, Remtulla H et al (1993) Neurophysiological assessment of failure to wean from a ventilator. Can J Neurol Sei 20:S28Google Scholar
  11. 11.
    Maher J, Rutledge F, Remtulla H et al (1995) Neuromuscular disorders associated with failure to wean from the ventilator. Intens Care Med 21:737–743CrossRefGoogle Scholar
  12. 12.
    Segredo V, Caldwell JE, Matthay MA et al (1992) Persistent paralysis in critically ill patients after long-term administration of vecuronium. New Engl J Med 327:524–528PubMedCrossRefGoogle Scholar
  13. 13.
    Douglass JA, Tuxen DV, Home M et al (1991) Myopathy in severe asthma. Amer Rev Respir Dis 146:517–519Google Scholar
  14. 14.
    Sheth RD, Pryse-Philips WEM (1994) Post-ventilatory quadriplegia: Critical illness polyneuropathy in childhood. Neurology 44:2:A169Google Scholar
  15. 15.
    Dimachkie M, Austin SG, Slopis JM et al (1994) Critical illness polyneuropathy in childhood. J Child Neurol 9:207Google Scholar
  16. 16.
    Bolton CF (1997) EMG in the paediatric critical care unit. In: Jones HR, Bolton CF, Harper M (eds) Paediatric electromyography. Raven Press (in press)Google Scholar
  17. 17.
    Widjicks EFM, Fulgham JR (1994) Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy. Muscle & Nerve 17:1494–1495Google Scholar
  18. 18.
    Subramony SH, Carpenter DE, Raju S et al (1991) Myopathy and prolonged neuromuscular blockage after lung transplant. Crit Care Med 19;12:1580–1582PubMedCrossRefGoogle Scholar
  19. 19.
    Rossiter A, Souney PF, McGowan S et al (1991) Pancuronium-induced prolonged neuromuscular blockade. Crit Care Med 12:1583–1587CrossRefGoogle Scholar
  20. 20.
    Gooch JL, Suchyta MR, Balbierz JM (1991) Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 9:1125–1131CrossRefGoogle Scholar
  21. 21.
    Kupfer Y, Namba T, Kaldawi E et al (1991) Prolonged weakness after long-term infusion of vecuronium-bromide. Ann Intern Med 117:484–486Google Scholar
  22. 22.
    Barohn RJ, Jackson CE, Rogers SJ et al (1994) Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle & Nerve 17:647–654CrossRefGoogle Scholar
  23. 23.
    Giostra E, Magistris Mri, Pizzolato G et al (1994) Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Chest 106; 1:210–220PubMedCrossRefGoogle Scholar
  24. 24.
    Op de Coul AAW, Verheul GAM, Leyten ACM et al (1991) Critical illness polyneuromyopa- thy after artificial respiration. Clin Neurol Neurosurg 93:27–33CrossRefGoogle Scholar
  25. 25.
    Bolton CF (1994) Muscle weakness and difficulty in weaning from the ventilator in the critical care unit (editorial). Chest 106:1–2PubMedGoogle Scholar
  26. 26.
    Lacomis D, Smith TW, Chad DA (1993) Acute myopathy and neuropathy in status asthmati- cus: Case report and literature review. Muscle & Nerve 16:84–90CrossRefGoogle Scholar
  27. 27.
    Danon MJ, Carpenter S (1991) Myopathy and thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle & Nerve 14:1131–1139CrossRefGoogle Scholar
  28. 28.
    Hirano M, Ott BR, Raps EC (1992) Acute quadriplegic myopathy: complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 42:2082–2087PubMedGoogle Scholar
  29. 29.
    Sitwell LD, Weinshenker BG, Monpetit V et al (1991) Complete ophthalmoplegia as a comph- cation of acute corticosteroid and pancuronium-associated myopathy. Neurology 41:921–922PubMedGoogle Scholar
  30. 30.
    Karpati G, Carpenter S, Eisen AA (1972) Experimental core-like lesions and nemaline rods: A correlative morphological and physiological study. Arch Neurol 27:247–266CrossRefGoogle Scholar
  31. 31.
    Clowes GHA, George BC, Villee CA (1983) Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. New Engl J Med 308:545–552PubMedCrossRefGoogle Scholar
  32. 32.
    Penn AS (1986) Myoglobinuria. In: Engel AG, Banker BQ (eds) Myology. Vol 2. McGraw- Hill 1792Google Scholar
  33. 33.
    Ramsay DA, Zochodne DW, Robertson DM et al (1993) A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropath Exper Neurol 52:4:387–398CrossRefGoogle Scholar
  34. 34.
    Zochodne DW, Ramsay DA, Saly V et al (1994) Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle & Nerve 17:285–292CrossRefGoogle Scholar
  35. 35.
    Helliwell TR, Coakley JH, Wagenmakers AJM et al (1991) Necrotizing myopathy in critically-ill patients. J Pathol 164:307–314PubMedCrossRefGoogle Scholar
  36. 36.
    Latronico N, Flavio F, Daniela R et al (1996) Critical illness myopathy and neuropathy. Lancet 347:1579–1582PubMedCrossRefGoogle Scholar
  37. 37.
    Rich MM, Bird SJ, Raps EC et al (1997) Direct muscle stimulation in acute quadriplegic myopathy. Muscle & Nerve 20:665–673CrossRefGoogle Scholar
  38. 38.
    Lacomis D, Giuliani M, Van Cott A et al (1996) Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Am Neurol Association 40:645–654Google Scholar
  39. 39.
    Berek K, Margreiter J, Willeit J et al (1996) Polyneuropathies in critically ill patients: A prospective evaluation. Intensive Care Med 22:849–855PubMedCrossRefGoogle Scholar
  40. 40.
    Leijten ESS, De Weerd AW et al (1996) Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med 22:856–861PubMedCrossRefGoogle Scholar
  41. 41.
    Witt NJ, Zochodne DW, Bolton CF et al (1991) Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176–184PubMedCrossRefGoogle Scholar
  42. 42.
    Low PA, Tuck RR, Takeuchi M (1987) Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK et al (eds) Diabetic neuropathy. WB Saunders 268–277Google Scholar
  43. 43.
    Wemig A, Pecot-Dechavassine M, Stover H (1980) Sprouting and regression of the nerve at the frog neuromuscular junction in normal conditions and after prolonged paralysis with curare. J Neurocytol 9:277–303CrossRefGoogle Scholar
  44. 44.
    Hund E, Wolfgang F, Drieger D et al (1996) Critical illness polyneuropathy: Clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med Vol 24, No 8CrossRefGoogle Scholar
  45. 45.
    Minetti C, Hirano M, Morreale G (1996) Ubiquitin expression in acute steroid myopathy with loss of myosin thick filaments. Muscle & Nerve 19:94–96CrossRefGoogle Scholar
  46. 46.
    Showalter C, Engel A (1997) Acute quadriplegic myopathy: Analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle & Nerve 20:316–322CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1998

Authors and Affiliations

  • C. F. Bolton

There are no affiliations available

Personalised recommendations